Canakinumab for Treatment of Adult Onset Still's Disease
Treatment of Refractory Adult-onset Still's Disease With Anakinra: a Randomized Study
Efficacy and Safety of Tocilizumab in Adult's Still Disease
Therapeutic Use of Tadekinig Alfa in Adult-onset Still's Disease
Interleukin-1 Trap to Treat Autoinflammatory Diseases
† Study has passed its completion date and status has not been verified in more than two years.